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artery was noted in case of re-do procedures, though vessel wall
irregularities was noted in few cases.
Conclusion: Postprocedural patency in radial interventions
depends upon the nature and complexity of the coronary disease.
Females were more prone to develop puncture site complications.
Tobacco usage has the strongest association with the postproce-
dural non-patency, followed by dyslipidemia. In diabetics, mean
internal radial diameterwas found to be low,whereas hypertension
was not associated signiﬁcantly with the non-patency. Patencywas
higher in taller persons orwith larger BSA, but less in short or in lean
and thin persons, or with smaller BSA. More the wrist diameter or
circumference, greater was the chances of patency. Presence of
pulse does not always indicate the artery is patent, as presence of
good collaterals to maintain circulation may give rise to palpable
pulse. Whereas absence of pulse always indicates that there is
signiﬁcantﬂowreductionornon-patency.There isnegligiblechance
of developing non patent radial artery in cases of repeat procedures
providedcaseselection isdonebymaintaining theabovementioned
exclusion criteria. Re-do procedure does not cause reduction in the
internal diameter of the artery.
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Background: The safety and efﬁcacy of everolimus eluting bioab-
sorbable vascular scaffold (BVS) in themanagement of ‘‘ST’’ eleva-
tion myocardial infarction (STEMI) is yet to be established.
Aims: To evaluate immediate and short-term safety and efﬁcacy of
the everolimus-eluting BVS compared with non BVS drug eluting
stent (DES) in patients with STEMI.
Methods: From January 2013 to December 2014, 220 patients with
STEMI were included in this study. Among them, 35 patients
treated with BVS were compared with a control group composed
of 180 consecutive patients who underwent non BVS DES implan-
tation in the same time period. The incidence of major adverse
cardiac events (MACE: stent thrombosis: death, non-fatal myocar-
dial infarction, or reintervention) before discharge and up to six
months was evaluated.
Results: Single vessel disease was more frequent whereas, double
and triple vessel disease was less frequent in BVS group. Proce-
dural characteristics were also similar between groups, except for
the use of post dilation ( p = 0.04). Procedural success, in-hospital,
and up to six-month MACE rates were similar between both
groups. Deﬁnite or probable in-stent/scaffold thrombosis did not
occurred in BVS patients, though two patients during the index
admission and another two patients in the ﬁrst month after DES
implantation had stent thrombosis.
Conclusion: The use of theAbsorb BVS in this cohort reﬂecting day-
to-day real world clinical practice is feasible and associated with
good procedural safety, and angiographic success rate.
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Background: Although recent studies have demonstrated the
safety and efﬁcacy of everolimus eluting bioabsorbable vascular
scaffold (BVS) in themanagement of stable coronary artery disease
(CAD), but there is lack of data regarding use of BVS for primary
percutaneous coronary intervention (PCI) in management ST seg-
ment elevation myocardial infarction (STEMI).
Aims: To evaluate immediate and short-term safety and efﬁcacy of
the everolimus-eluting BVS in patients with STEMI.
Methods: From January 2013 to December 2014, patients with
STEMI who received BVS implantation during primary PCI were
included in this study.
Results: Among 220 patients of primary PCI, 35 patients received
BVS stent within this study period. Mean age was 59.2  9 years.
Mean duration of follow-up was 11.5  5 months. Eighty percent
patients had single vessel CAD. Femoral access was used in 51%
cases. Mean door-to-balloon time was 93  30 min. Anterior wall
STEMI was more frequent than inferior wall STEMI involving right
coronary artery territory. Mean BVS length and BVS diameter per
patient was 24.6  4.7 mm and 3.2  0.3 mm, respectively. About
66% patients received thrombo aspiration during PCI and throm-
bolysis inmyocardial infarction (TIMI) III ﬂowwas achieved in 94%
patients. Procedural successwas achieved in 94%of the cases. Only
one case had non-cardiac death within one month.
Conclusion: The use of the Absorb BVS in this cohort reﬂecting day-
to-day real world clinical practice is feasible and associated with
good procedural safety and angiographic success rate.
360 degree ACS intervention
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Case history: A 61-year-old male; Diabetes Mellitus on OHA; K/C/
OMinor CAD (CAG in 2012); Presented with Acute Infero Posterior
wall MI, taken up for Primary Angio Plasty elsewhere, deferred due
to complex anatomy, was thrombolyzed and referred to our hos-
pital for further management.
Techniques/hardware attempted: Guides: JR, AL1, 2; Wires: BMW,
Fielder XT, Grand Slam; Balloon: 1.25, 1.5, 2, 2.5, NC; Stent:
2.75  15, 3  15; Microcatheter: Fine Cross 1.7F; Guideliner: 6F.
Techniques: Double Wire; Conal Artery balloon occlusion; Double
catheter/double wire technique; Double catheter + guideliner
+ grandslam.
Take home message: Tortuosity is always a night mare; Double
GUIDE concept changes device interactions dramatically; Amplatz
Guide + Guideliner + 2 Grandslam provide incremental support;
Even in ACS, hardware choice and Bigger Shelf support matters.
Provisional observation of FFR outcome




Introduction: Fractional ﬂow reserve (FFR) is a very handy tool to
determine the precise hemodynamic signiﬁcance of intermediate
epicardial coronary artery stenosis and thus to take appropriate
clinical judgment. Several trails already have identiﬁed its utility
in different clinical set up and parameters but it is still to be
adopted as must have tools in Indian Interventional Niche
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wherever applicable. Our study tried to point out its implication in
intermediate stenosis and how it is more decisive than software
derived measurement (QCA) in a real world scenario.
Procedure: Total 27 patients (age 62.77  11.39 years) who received
FFR for intermediate stenosis, were included in this study. All
patients had evidence of ischemia either as stable angina
(56.26%), unstable angina (33.33%) or postMI angina (7.41%). Hyper-
tension (74.07%) and diabetes mellitus (29.63%) are most prevalent
risk factors present within patient group. In 85.19% cases, patients
have multi-vessel disease. Total patient group is subdivided into
left alone (70.37%) and stented (29.63%) as per FFR cut off value (0.8)
and both were kept under stringent medical management with
optimal antiplatelet and statin therapy. Mean follow-up period
was 18 months and primary outcome was recorded in reference to
TLR (target lesion re-stenosis) or MACE (major adverse cardiac
event).
Result: In 18months follow-up, patients of both subgroup emerged
quite well in outcome of the procedure as only 2 TLR (7.4%) have
identiﬁed one from each sub-group. In both the cases, HTN andDM
are concomitantly present as risk factors.
We observed that there is statistically highly signiﬁcant difference
in FFR score between two sub groups (0.88 vs. 0.75, p < 0.001), while
this is non-signiﬁcant in QCA score (0.66 vs. 0.71, p = 0.08) in
respective sub groups.
Both left alone sub-group and stented sub-group showed good
outcome (94.74% and 87.7%) in respect to disease free life and
Kaplan–Meier analysis for survival also corroborated the same
as it predicted excellent survival in both left alone sub groups
(0.9444; CI: 0.706–0.994) and stented sub-group (0.888; CI: 0.506–
0.994).
Inference: FFR is effective tool in deciding hemodynamically non-
signiﬁcant epicardial coronary artery stenosis with similar out-
come as compared to global PCI outcome. Moreover, this is proved
to be much superior to QCA score in judging effectiveness of
the management strategies and avoiding unnecessary coronary
stenting.
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Background: Trans-catheter closure of perimembranous defects
with the asymmetric device has been controversial due to a high
incidence of atrioventricular conduction disturbances. The use of
Amplatz duct occluders in carefully selected patients may reduce
this complication.
Aim: To evaluate the immediate and mid-term incidence of AV
conduction disturbances following transcatheter device closure of
perimembranous ventricular septal defect device (PMVSD) using
Amplatzer Duct Occluders.
Methods: Twenty-one patients with perimembranous VSD with
signiﬁcant left-to-right shunt (assessed by left ventricular dimen-
sion Z scores) were selected for trans-catheter closure. Patients
with weight <10 kg or with defects within 4 mm distance from the
aortic valve, or with large defects (size greater than the aortic
annulus) were excluded. The size of the device was chosen based
on the trans-esophageal dimension of the defect at the LV end
(2 mm larger device size for ADO 1 and 1 mm larger for ADO II).
Sixteen patients were available for follow-up, of which 13 had their
defects closed with the ADO I device and three with the ADO II
device. Patients were followed up clinically and with electrocar-
diography and trans-thoracic echocardiography at 1, 6, and
12 months. Holter monitoring was performed in all patients at
six months.
Results: Themean age of the patients was 10.2  9.2 years, and the
mean weight was 23.6  15.06 kg. The mean defect size (at the LV
end) was 4.02  0.98 mm. The mean follow-up period was 12.09
 1.92 months. The procedure was successful in all 21 patients,
with complete closure of the defect by 24 h as assessed on TTE. No
patient developed signiﬁcant aortic regurgitation. One patient had
device (ADO II) embolization to the left pulmonary artery within
24 h. The device was retrieved percutaneously and the defect was
closed successfully with ADO I device of a larger size. One patient
developed transient RBBB on table, which reverted spontaneously
allowing successful completion of the procedurewith noAV blocks
thereafter. No patients developed AV blocks in the peri-procedural
period. In 16 patients who were followed up, all were asympto-
matic on follow-up. None developed AV conduction disturbances
on ECG or Holter examination.
Conclusion: In carefully selected patients with small to moderate
perimembranous VSDs, transcatheter closure using the ADO I and
ADO II device can be considered to be a safe and effective alter-
native to surgery, with no AV conduction blocks observed at mid-
term follow-up. Longer follow-up with a larger study population is
desirable.
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Background: Signiﬁcant unprotected left main coronary artery
disease occurs in 5–7% of patients undergoing coronary angiogra-
phy (CAG). This study has focused on safety and efﬁcacy of LMCA
stenting to determine whether it provides a true alternative to
CABG.
Materials and methods: From July 2013 to February 2015, 50
patients underwent LMCA stenting. LMCA stenting was performed
in patients with following criteria (1) Patients with LMCA stenosis
more than 50% and evidence of myocardial ischemia and who
denied CABG as revascularization procedure. (2) Patients with
signiﬁcant ostioproximal lesion of LAD or LCX, who are planned
to be treated with LMCA to LAD or LMCA to LCX stenting. (3)
Patients with bail out LMCA stenting. (4) Stenting of unprotected
LMCA stenosis in selected patients.
Results: Mean age was 53.14  9.60 years. 18 patients who under-
went LMCA stenting presentedwith STEMI, 9 (18%) had NSTEMI, 10
(20%) had unstable angina and 13 (26%) had chronic stable angina.
6 patients had protected LMCAand the rest had unprotected LMCA.
On CAG, 16 (32%) patients had ostial LMCA lesion, 12 (24%) hadmid
LMCA lesion, distal LMCA was diseased in 6 (12%). In emergency
situation, 2 bail out LMCA stenting were done for treatment of
LMCA dissection. 22 (44%) patients had LMCA stenosis less than
50%, 6 (12%) had stenosis between 50 and 70%, 19 (38%) had 71–90%
stenosis and 3 had more than 90%. 42 (84%) patients had low
syntax score, 6 (12%) had intermediate and 2 (4%) had high syntax
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